Our Pipeline

Our goal is to transform the prevention and treatment of infectious diseases and cancers to significantly improve the lives of patients by developing and commercializing a new class of ‘‘off-the-shelf’’ immunotherapeutics.

We are leveraging our modular arenavirus platform to develop the following product candidates for multiple infectious diseases and cancers - the efficacy of our TheraT®* and VaxWave®* platforms is being tested all across our pipeline:

*Registered in Europe; Pending in the US